Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide funding outage notice has been removed from the page, and the rest of the study record remains visible.
    Difference
    0.7%
    Check dated 2025-11-17T06:28:37.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new version entry dated 2024-11-27 appears in the record history, showing updated study and recruitment status for NCT05560399. This reflects ongoing updates to the trial's official status on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2025-11-03T01:09:58.000Z thumbnail image
  4. Check
    44 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    12%
    Check dated 2025-10-05T10:00:26.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Updates the page version from v3.0.2 to v3.1.0, indicating a new release tag without changing core content.
    Difference
    0.3%
    Check dated 2025-09-28T03:12:49.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' link was removed, representing a minor navigation change with no substantive content updates.
    Difference
    0.7%
    Check dated 2025-09-13T17:07:25.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-06T14:43:03.000Z thumbnail image

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.